-
July 18, 2008
Antidepressants linked to non-Hodgkin lymphoma
NEW YORK (Reuters Health) - Long-term users of so-called tricyclic antidepressants are at increased risk of non-Hodgkin lymphoma (NHL), new research confirms.
-
June 13, 2008
Hair dye may boost lymphoma risk: study
NEW YORK (Reuters Health) - A new study suggests that use of hair dye may increase the risk of certain types of non-Hodgkin lymphoma (NHL), a blood cancer involving the lymph nodes.
-
May 27, 2008
Gum disease may raise cancer risk, study finds
CHICAGO (Reuters) - Gum disease may increase the risk of developing cancer, researchers said on Tuesday.
-
May 21, 2008
Cancer risk soars in HIV-infected people: study
WASHINGTON (Reuters) - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
-
May 19, 2008
Cancer risk mixed in rheumatoid arthritis patients
NEW YORK (Reuters Health) - People with rheumatoid arthritis are more likely to develop lymphoma or lung cancer, but are less likely to develop colorectal cancer or breast cancer, according to American and Canadian researchers.
-
April 16, 2008
U.S. Sen. Specter has Hodgkin's disease recurrence
WASHINGTON (Reuters) - Republican Sen. Arlen Specter said on Tuesday he has been diagnosed with a recurrence of Hodgkin's disease, a cancer of the lymph system, but expected to continue working and campaigning for re-election in Pennsylvania.
-
April 11, 2008
Smoking, drinking imperil lymphoma survival
NEW YORK (Reuters Health) - Smoking and moderate-to-high alcohol consumption negatively affect the survival of people with non-Hodgkin lymphoma, dubbed NHL, a European study shows.
-
April 8, 2008
Frequent blood donation doesn't boost cancer risk
NEW YORK (Reuters Health) - Frequent blood donation is not harmful to your health, a new study confirms.
-
April 7, 2008
Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in lymphomas difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
-
April 3, 2008
Racial differences seen in Hodgkin's disease
NEW YORK (Reuters Health) - Black children with Hodgkin's disease, also referred to as Hodgkin's lymphoma, a cancer of the lymph system, appear to be more likely to have relapses compared with their white counterparts. However, the overall 5-year survival rate is essentially the same for both groups, researchers report in the Journal of Clinical Oncology.
-
March 14, 2008
Many lymphoma survivors have psychological scars
NEW YORK (Reuters Health) - Almost 40 percent of survivors of non-Hodgkin's lymphoma report some degree of emotional distress in the years after diagnosis, according to North Carolina-based researchers.
-
March 12, 2008
Thyroid cancer patients at risk of second cancer
NEW YORK (Reuters Health) - After treatment for thyroid cancer, patients may face a slightly increased risk of developing a second primary malignancy elsewhere in the body, research suggests.
-
February 29, 2008
Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer
Hodgkin’s lymphoma survivors may be at risk for secondary cancer. These findings were recently reported in the British Journal of Cancer.
-
February 26, 2008
Hepatitis C: a risk factor for lymphoma
NEW YORK (Reuters Health) - Canadian researchers have confirmed an association between hepatitis C virus (HCV) infection and an increased risk of non-Hodgkin's lymphoma, according to their report in the International Journal of Cancer.
-
February 5, 2008
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma
A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics and possible treatment options for both types of disease. These results were published in the Journal of Clinical Oncology.
-
January 9, 2008
Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors
According to the results of a study published in the Annals of Oncology, annual screening mammography may miss some cases of early invasive breast cancer among young Hodgkin’s lymphoma survivors who were treated with supradiaphragmatic (above the diaphragm) radiation therapy.
-
January 1, 2008
Some sun may guard against non-Hodgkin's lymphoma
NEW YORK (Reuters Health) - Recreational sun exposure could help prevent a type of blood cancer involving the lymph nodes called non-Hodgkin's lymphoma (NHL), according to pooled data from 10 studies.
-
December 28, 2007
Childhood cancer survivors at risk for new cancers
NEW YORK (Reuters Health) - Survivors of childhood cancers have a markedly increased risk of developing new cancers later on, research indicates.
-
December 10, 2007
Gentler chemo helps patients survive lymphoma
WASHINGTON (Reuters) - A gentler chemotherapy regimen may help some lymphoma patients better tolerate and benefit from bone marrow transplants, and the combination could even cure them, U.S. doctors reported on Monday.
-
November 9, 2007
Chemotherapy plus Radiation Recommended as Standard of Care in Early Hodgkin’s
According to an article recently published in the New England Journal of Medicine, chemotherapy plus involved-field radiation should become the standard of care for early-stage Hodgkin’s disease.
-
October 1, 2007
Lifestyle factors, obesity impact lymphoma risk
NEW YORK (Reuters Health) - Body size and patterns of smoking and drinking appear to modulate a person's risk of developing Hodgkin's and non-Hodgkin's lymphoma, a study shows.
-
June 6, 2007
Sun exposure may reduce malignant lymphoma risk
NEW YORK (Reuters Health) - At last, some positive health effects of sitting in the sun! Physicians have found that recreational sun exposure is apparently associated with reduced risk for cancers of the lymph system, or malignant lymphomas, German researchers report in the International Journal of Cancer. They also found that the association is stronger for some types of lymphoma than for others.
-
June 1, 2007
Sunlight exposure may increase lymphoma risk
NEW YORK (Reuters Health) - In women, ultraviolet radiation exposure from time spent in the sun appears to boost the risk of non-Hodgkin's lymphoma -- a type of cancer involving the body's lymphatic system, according to a large "population-based" study.
-
March 20, 2007
Cardiac risk persists long after Hodgkin's therapy
NEW YORK (Reuters Health) - The improved prognosis of patients diagnosed with Hodgkin's disease is tempered by the increased risk of cardiovascular disease, a side effect of treatment that can persist for decades.
-
February 14, 2007
Patients with Hodgkin’s at Risk for Heart Attack Later in Life
According to results from the Journal of the National Cancer Institute, patients treated for Hodgkin’s lymphoma are at an increased risk for death from a heart attack for 25 years.
-
January 22, 2007
Smoking May Increase Risk of Hodgkin’s Lymphoma
According to the results of a study published in the journal Epidemiology, smokers have an increased risk of developing Hodgkin’s lymphoma.
-
January 3, 2007
Increase in Hodgkin’s Lymphoma in HAART Era
Among people living with AIDS, the frequency of Hodgkin’s lymphoma has increased since the introduction of highly active antiretroviral therapy (HAART). These results were published in the journal Blood.
-
November 7, 2006
Neulasta® Safe and Effective for Hodgkin’s Patients Treated with ABVD Chemotherapy
Among Hodgkin’s lymphoma patients treated with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy every two weeks, use of Neulasta® (pegfilgrastim) was safe and allowed most patients to receive their chemotherapy on schedule. These results were published in the European Journal of Cancer.
-
October 31, 2006
More Radiation Therapy Is Not Better for Elderly Patients with Hodgkin’s Lymphoma
According to a study published in the Annals of Oncology, extended-field radiation therapy results in worse survival than involved-field radiation therapy among elderly patients with early-stage unfavorable Hodgkin’s lymphoma.
-
August 29, 2006
Addition of Interferon Following an Autologous Stem Cell Transplant Provides Impressive Outcomes for Children with Recurrent Hodgkin's
According to an article recently published in Bone Marrow Transplantation, the addition of the biologic agent interferon following an autologous stem cell transplant provides impressive outcomes for pediatric patients with Hodgkin's lymphoma that has stopped responding to prior therapies.
-
August 18, 2006
Study Addresses Treatment of Older Hodgkin’s Patients
According to a study published in the Annals of Oncology, treatment with radiation therapy alone may be an option for older patients with early-stage Hodgkin’s Lymphoma.
-
July 31, 2006
Certain Variables Predict Risk of Secondary Leukemia After Stem Cell Transplant
According to an article recently published in the Journal of Clinical Oncology, patients diagnosed with lymphoma who were previously treated with radiation therapy, those treated with four or more chemotherapy regimens, and those who take five days to collect enough stem cells for a transplant are at a higher risk of developing myelodysplastic syndromes or acute myeloid leukemia associated with a stem cell transplant.
-
February 2, 2006
Declining Risk of AML After Hodgkin’s Lymphoma
According to a study published in the Journal of the National Cancer Institute, the risk of developing acute myeloid leukemia (AML) after treatment for Hodgkin’s lymphoma has declined over time. This decline may be due to changes in the chemotherapy regimens used to treat Hodgkin’s lymphoma.
-
January 4, 2006
PET/CT Changes Staging and Treatment of Early Lymphoma
Use of PET/CT (combined positron emission tomography and computed tomography) after CT (computed tomography) for initial staging of lymphoma changed treatment decisions in roughly one-quarter of patients with non-Hodgkin’s lymphoma (NHL) and roughly one-third of patients with Hodgkin’s disease (HD). Changes in staging and treatment were most likely for patients with stage I or stage II disease based on CT. These results were published in the Annals of Oncology.
-
December 20, 2005
Patients with Unfavorable Risk Hodgkin’s Lymphoma May Not Benefit from More Intensive Therapy
Researchers from Germanyhave reported that more intensive chemotherapy and increased dose of radiation therapy did not benefit patients with unfavorable Hodgkin’s lymphoma. Another study, from the European Organization for Research and Treatment of Cancer (EORTC) also failed to show a benefit of six versus four cycles of chemotherapy. These two studies were presented at the 47th Annual Meeting of the American Society of Hematology in Atlanta in December of 2005.
-
December 2, 2005
Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid Complications
According to a recent article published in the Annals of Oncology, survivors of Hodgkin’s lymphoma have a significantly increased rate of cardiac and thyroid complications than their siblings. In addition, survivors tend to have more fatigue than their siblings; however, this may in part be associated with cardiac issues.
-
November 2, 2005
Risk of Second Cancers After Hodgkin’s Lymphoma Is Similar Across Treatment Groups
Compared to treatment with conventional therapy alone, treatment of Hodgkin’s lymphoma with conventional therapy followed by high-dose therapy and autologous stem-cell transplantation does not further increase the risk of second cancers, according to a study published in the Journal of Clinical Oncology.
-
October 21, 2005
ABVD Remains Best Treatment for Advanced Hodgkin’s Lymphoma
According to an early online publication in the Journal of Clinical Oncology, the chemotherapy regimen referred to as ABVD appears to remain the best treatment option for advanced Hodgkin’s lymphoma. Results were also presented at the 2004 annual meeting of the American Society of Clinical Oncology (ASCO).
-
October 19, 2005
Reduced Radiation Dose May Be Effective for Early Hodgkin’s
According to results presented at the 47th annual meeting of the American Society of Therapeutic Radiation Oncology (ASTRO), drastically reducing radiation doses may be as effective as higher doses in the treatment of early Hodgkin’s lymphoma. These reduced doses may prevent potentially debilitating long-term side effects.
-
October 19, 2005
Radiation Therapy Does not Improve Survival for Patients with Hodgkin’s Lymphoma
The Journal of Clinical Oncology has recently published a study reporting that there is no survival benefit among patients treated with chemotherapy and radiation when compared to patients treated with chemotherapy alone.
-
October 7, 2005
Epstein-Barr Virus and Survival with Hodgkin’s Lymphoma
The presence of Epstein-Barr virus in tumor cells is associated with better survival among young Hodgkin’s lymphoma patients and worse survival among older Hodgkin’s lymphoma patients, according to a study published in the Journal of Clinical Oncology.
-
October 6, 2005
Family History Associated with Increased Risk of Non-Hodgkin’s and Hodgkin’s Lymphoma
According to a recent article published in the Journal of the National Cancer Institute, a family history of hematopoietic (blood or lymph-related) cancers increases the risk of non-Hodgkin’s and Hodgkin’s lymphoma.
-
July 21, 2005
Interim PET Scan May Predict Outcome of Hodgkin’s Lymphoma Therapy
A recent article in the Annals of Oncology reports that Positive Emission Tomography (PET Scan) performed after two or three cycles of chemotherapy is an early and accurate predictor of progression-free survival and overall survival in patients with Hodgkin’s lymphoma.
-
June 10, 2005
Reduced Intensity Transplants Show Promise for Hodgkin’s Lymphoma
A recent study performed in the United Kingdom reports that approximately 40 percent of patients with resistant Hodgkin’s Lymphoma can be successfully treated with a lower intensity stem cell transplant from a related or unrelated donor. These results were recently published in the June issue of The Lancet.
-
October 26, 2004
Gemzar®/Cisplatin/Dexamethasone Effective in Relapsed Hodgkin’s Disease
According to a recent article published in Annals of Oncology, the chemotherapy combination consisting of Gemzar® (gemcitabine) and cisplatin (Platinol®) used in addition to the steroid dexamethasone is an effective treatment regimen for patients with relapsed Hodgkin’s lymphoma.
-
October 11, 2004
Some Children with Hodgkin’s Disease Can Skip Radiation Therapy
Researchers from Germany have reported that children with Hodgkin’s disease who achieve a complete remission after chemotherapy can skip radiation therapy altogether without a negative impact on their survival. These results were presented in the plenary session at the American Society of Therapeutic Radiology and Oncology annual meeting held in Atlanta GA, Oct 2-7, 2004.
-
September 29, 2004
Cryopreserved Ovarian Tissue Results in Live Birth in Hodgkin’s Patient
According to a recent article in the Lancet, the cryopreservation of ovarian tissue for 6 years has resulted in a live birth in a woman who underwent treatment for Hodgkin’s disease.
-
September 1, 2004
PET Scans More Effective Than CT in Lymphomas
According to a recent article published in the British Journal of Cancer, positron emission tomography (PET) scans are more effective at detecting residual cancer after therapy than computed tomography (CT) scans in patients with Hodgkin’s disease (HD) or non-Hodgkin’s lymphoma (NHL).
-
August 4, 2004
Cardiac Complications Common among Patients who Received Radiation to the Chest for Hodgkin's Disease
According to a recent article published in the Journal of Clinical Oncology, patients who received radiation to the chest for treatment of Hodgkin's disease at a young age have a high rate of heart (cardiac) complications several years following treatment. Patients who underwent this treatment should be monitored closely and routinely for cardiovascular defects.
-
June 24, 2004
ABVD Remains Standard of Care for Hodgkin’s
According to results recently presented at the 40th annual meeting of the American Society of Clinical Oncology, the chemotherapy regimen referred to as ABVD remains the standard of care for the chemotherapy treatment of Hodgkin’s lymphoma.